Tag: gets

Posted on

Teva Pharmaceutical Industries Ltd Gets FDA Green Signal For Its Acute Asthma … – Bidness ETC


Bidness ETC

Teva Pharmaceutical Industries Ltd Gets FDA Green Signal For Its Acute Asthma …
Bidness ETC
Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA), the world's largest seller of generic drugs based in Israel, has yet another victory to add to its success story. Its acute asthma inhaler has finally pocketed the approval from the US Food and …
First Breath-Actuated, Dry-Powder Inhaler for Acute Asthma ApprovedMonthly Prescribing Reference
FDA approves ProAir RespiClick for treatment of acute asthma symptomsHealio
FDA clears Teva asthma med (TEVA)Seeking Alpha (registration)
Arutz Sheva –Medscape
all 17 news articles »

View full post on asthma – Google News

Posted on

UofL gets $2.3 million for asthma research – The Courier-Journal


The Courier-Journal

UofL gets $2.3 million for asthma research
The Courier-Journal
A research team at the University of Louisville has been awarded a $2.3 million grant from the National Institute on Aging to study asthma triggers in older adults. Barbara Polivka, of the UofL School of Nursing, and her interdisciplinary team will …
UofL researchers to study asthma triggers in older adultsThe Lane Report
Researchers to examine asthma triggers in older adultsPhys.Org

all 4 news articles »

View full post on asthma – Google News

Posted on

Jubilant Life gets USFDA nod for generic anti-asthma tablets – Economic Times

Jubilant Life gets USFDA nod for generic anti-asthma tablets
Economic Times
NEW DELHI: Drug firm Jubilant Life Sciences has received final approval from the US health regulator for generic Montelukast Sodium chewable tablets used in the treatment of asthma and to relieve symptoms of seasonal allergies. "The company has …
Jubilant Life Sciences gets ANDA nod for MontelukastMyiris.com

all 7 news articles »

View full post on asthma – Google News

Posted on

AstraZeneca Gets Positive Results for Asthma Drug – Drug Discovery & Development

AstraZeneca Gets Positive Results for Asthma Drug
Drug Discovery & Development
AstraZeneca announced that The Lancet Respiratory Medicine has published positive safety and efficacy data from a Phase 2b study evaluating benralizumab, a novel investigational monoclonal antibody, in patients with severe, uncontrolled asthma and …
AstraZeneca gets some upbeat asthma data to back would-be IL-5 blockbusterFierceBiotech
AstraZeneca share price: Novel drug shows positive results for severe asthmaiNVEZZ
AstraZeneca's benralizumab succeeds in severe asthmaPharmaTimes

all 5 news articles »

View full post on asthma – Google News

Posted on

AstraZeneca gets some upbeat asthma data to back would-be IL-5 blockbuster – FierceBiotech

AstraZeneca gets some upbeat asthma data to back would-be IL-5 blockbuster
FierceBiotech
Benralizumab–an IL-5 antibody–reduced the rate of asthma exacerbations, hitting the primary endpoint in the trial, says AstraZeneca ($AZN). But the study flagged weak results for the low end of the doses used in the trial, with the top dose doing …
AstraZeneca share price: Novel drug shows positive results for severe asthmaiNVEZZ
AstraZeneca's benralizumab succeeds in severe asthmaPharmaTimes

all 4 news articles »

View full post on asthma – Google News

Posted on

GSK’s Asthma Treatment Gets FDA Approval – Bidness Etc


Bidness Etc

GSK's Asthma Treatment Gets FDA Approval
Bidness Etc
Yesterday, GlaxoSmithKline plc (GSK) announced that the Food and Drug Administration (FDA) has given marketing approval for its drug Arnuity Ellipta, developed as an asthma treatment in patients aged 12 and older. Asthma is a lingering lung disease …
FDA OKs New Maintenance Asthma Treatment Arnuity ElliptaMedscape
FDA approves GSK asthma medicinePhiladelphia Business Journal (blog)
FDA approves GSK's Arnuity Ellipta for treating asthmaHealio
Monthly Prescribing Reference –News-Medical.net –The Pharma Letter
all 21 news articles »

View full post on asthma – Google News